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Hepatitis C virus (HCV) sequences recovered from serum, peripheral blood mononuclear cells (PBMCs), and various
tissues from human immunodeficiency virus type 1 (HIV-1) positive patients were compared by single strand conformational
polymorphism (SSCP) and sequencing. In five patients, paired serum and PBMCs samples were analyzed while in two other
patients multiple autopsy tissues were studied. Sequences amplified from the NS5 and E2 regions were consistently identical
in the same patient; however, three PBMCs samples and three different tissue samples (pancreas and adrenal gland in one
patient and lymph node in the other patient) contained 59 untranslated region (59UTR) sequences that were different from
circulating sequences. The presence of 59 UTR sequences differing from circulating sequences correlated with the presence
of HCV RNA negative strand, as the latter was detected by a Tth-based strand-specific assay in all but one of these samples.
These two independent lines of evidence: viral sequence differences and the presence of RNA negative strand in the same
tissues strongly argue for the genuine presence of extrahepatic HCV replication, at least in the setting of HIV-1 infection.
© 1998 Academic Press
INTRODUCTION
The presence of extrahepatic hepatitis C virus repli-
cation remains a highly controversial issue. Several
groups of researchers have reported the detection of
HCV RNA negative strand, which is a replicative inter-
mediate, in peripheral blood mononuclear cells (PBMCs)
(Wang et al., 1992; Muller et al., 1993; Gabrielli et al.,
1994; Saleh et al., 1994), and it has been reported that
human T and B cell lines are capable of supporting a
productive infection (Shimizu et al., 1993; Nakajima et al.,
1996). However, in vitro cell culture studies do not nec-
essarily reflect actual events occurring in an infected
host, and the specificity of RT-PCR for the detection of
HCV RNA negative strand has been recently questioned
(Lanford et al., 1994). Thus, subsequent studies employ-
ing assays optimized for strand specificity either failed to
demonstrate the presence of viral negative strand in
PBMCs or found it to be extremely rare (Lanford et al.,
1995; Lerat et al., 1996; Laskus et al., 1997a).
Even less is known about HCV replication in other
tissues, as studies using strand-specific assays are few;
in a single published study Lanford et al. (Lanford et al.,
1995) did not detect HCV RNA negative strand in multiple
organs from a chronically infected chimpanzee. How-
ever, the results of this study should be interpreted with
caution, as it was conducted on a single ape that had a
low level of viral replication.
There are two major obstacles for the study of extra-
hepatic HCV replication. First, strand-specific assays are
relatively insensitive: in several studies they were found
to be at least 1 log less sensitive than standard RT-PCR
(Lanford et al., 1995; Lerat et al., 1996; Laskus et al.,
1997a,b). However, use of a highly sensitive assay is
critical as the replication at extrahepatic sites is likely to
be low and the titer of the negative strand is expected to
be 1 or 2 logs lower than the titer of the positive strand
(Lanford et al., 1995; Laskus et al., 1997a). Second, bio-
logical material other than PBMCs is generally not avail-
able and multiple tissue samples can be obtained only
during autopsy.
We reasoned that an investigation on extrahepatic
HCV replication could be performed on drug addicts
infected with human immunodeficiency virus type 1 (HIV-
1). This particular group offers several advantages: first,
HCV infection is almost uniform among drug addicts;
second, viral titers are usually elevated (Eyster et al.,
1991; Sherman et al., 1993) thus facilitating the detection
of extrahepatic replication sites; and third, because of
high mortality postmortem tissues samples are more
easily available.
In an effort to remedy the inherent sensitivity limita-
tions of strand specific assays, we compared HCV se-
quences amplified from PBMCs and various tissues with
those amplified from serum. We assumed that in the
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presence of passive virus absorption and/or contamina-
tion of these cells by circulating viral RNA, the amplified
sequences would be identical to those in serum, while in
the presence of independent replication, they might be
different. We were encouraged by a recently published
work documenting occasional discrepancies between
HCV quasispecies replicating in the liver and circulating
in the serum (Cabot et al., 1997).
HCV sequences were amplified by RT-PCR using prim-
ers specific for three different viral regions (59 untrans-
lated, NS5, and E2), and the amplified sequences were
compared by single-strand conformation polymorphism
(SSCP) and sequencing. At the same time all analyzed
samples were tested for the presence of HCV RNA neg-
ative strand using highly strand-specific Tth-based RT-
PCR, the sensitivity and specificity of which has been
determined using synthetic RNA template.
RESULTS
HCV in PBMCs
All three viral regions, 59UTR, NS5, and E2, were suc-
cessfully amplified from all five patients whose PBMCs
were studied. As illustrated in Fig. 1, SSCP analysis of
PCR products revealed the presence of indistinguishable
band patterns from PBMCs and serum, compatible with
the presence of identical viral sequences, for both NS5
and E2 regions. However, in patients 1, 4, and 5 the
59UTR sequences recovered from PBMCs were clearly
different from those recovered from serum. The presence
of different 59UTR viral sequences in these three cases
was subsequently verified by direct sequencing of PCR
products. As seen in Fig. 2, PBMCs and serum HCV
‘‘master’’ sequences differed by 2 to 14 nucleotides (1 to
7%) in the 200 nucleotide long fragment of viral genome
that was read. Since the ‘‘master’’ sequences were al-
ready different, the PCR products were not analyzed any
further. To exclude the possibility that PBMCs nonspe-
cifically concentrate a subset of circulating HCV popula-
tion, the following experiment was carried out. PBMCs
were collected from a single HCV-negative donor,
washed three times in PBS after which 5 3 106 of cells
were incubated in 2 ml of serum from three different HCV
positive subjects: one of these was patient 4 and the
other two were chronic hepatitis C patients before initi-
ation of antiviral therapy. After 2 h incubation at 37°C the
PBMCs were separated from sera, washed as before,
and both cells and sera were extracted and amplified as
described previously. Subsequent SSCP analysis did not
reveal any differences between serum- and PBMCs-de-
rived 59 region HCV sequences (not shown).
HCV RNA titers in serum and PBMCs ranged from 5 3
105 to 5 3 107 genomic eq/ml and 103 to 104 genomic
eq/2 to 3 3 10 6 cells, respectively (Table 1). HCV RNA
negative strand was not detected in any of the serum
samples; however, PBMCs from patients 1 and 4 were
positive for the presence of HCV RNA negative strand
when tested with Tth-based assay in two independent
experiments. Interestingly, these were the same patients
in whom SSCP analysis and direct sequencing revealed
the presence of different 59UTR sequences in PBMCs
and serum (Figs. 1 and 2).
HCV RNA in various tissues
59UTR and NS5 region sequences of HCV were suc-
cessfully amplified from all tissue samples in both stud-
ied patients; however, E2 region sequences were ampli-
fied in only one patient, as the other was persistently
negative despite applying several combinations of prim-
ers. As seen in Figs. 3 and 4, SSCP analysis of NS5 and
E2 sequences revealed the presence of identical band
patterns in all studied tissues from a given patient. How-
ever, this was not the case for 59UTR sequences: in
patient 6 sequences recovered from pancreas and ad-
renal gland and in patient 7 sequences recovered from
lymph node were persistently different from all other
samples in the same patient. These three PCR products
were further analyzed by sequencing and compared with
‘‘master’’ sequence recovered from serum, liver, and
other tissues.
Direct sequencing confirmed the presence of identical
‘‘master’’ sequence in all tissue samples from each pa-
tient; however, in the case of samples showing disparate
FIG. 1. Analysis by SSCP of HCV sequences amplified from PBMCs
and serum from five HIV-1 positive patients. Three different viral re-
gions were studied: 59UTR, NS5, and E2. Lanes S and C represent viral
sequences recovered from serum and PBMCs, respectively. All pa-
tients show identical band pattern for PBMCs and serum in NS5 and E2
regions; however, patients 1, 4, and 5 show different band patterns in
59UTR. The presence of identical and dissimilar 59UTR viral sequences
was verified by direct sequencing; these sequences are shown in
Fig. 2.
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SSCP band patterns, the sequencing ladder suggested
the presence of a mixture of overlapping products (not
shown). Consequently, the individual bands were ex-
tracted from the SSCP gel and sequenced after PCR
amplification (Fig. 2). As can be seen, in patient 6 viral
sequences recovered from the pancreatic and adrenal
gland tissue consisted of two different populations, one
being identical to the ‘‘master’’ sequence recovered from
other sites and the other differing from “master” se-
quence by one nucleotide substitution and one nucleo-
tide insertion. In patient 7, direct sequencing confirmed
the presence of identical ‘‘master’’ sequence in all sam-
ples; however, analogous to situation in the previous
patient, the sample that was different on SSCP analysis
was found to consist of two different viral populations.
One of these was identical to the consensus sequence,
and the other one differed by two nucleotide substitu-
tions (Fig. 2).
HCV RNA titers varied widely from tissue to tissue,
being the highest in the liver and at least several logs
lower at other sites (Table 2). Using Tth-based strand
specific assay, the presence of HCV RNA negative strand
was documented in both liver samples in titers that were
1 to 2 logs lower than the titers of the positive strand. In
addition, HCV RNA negative strands were detected in
pancreas and adrenal gland from patient 6 and in lymph
node tissue from patient 7 (Fig. 5). These results were
confirmed in two independent experiments using two
separate extraction procedures.
HCV RNA negative strand sequences recovered from
the extrahepatic sites were not used for SSCP compar-
isons as their low titer would make such an analysis
meaningless. The dangers associated with comparing
sequences of low titer templates are illustrated in Fig. 6.
In this case, 59UTR sequences were amplified from se-
rum and liver (both positive and negative strand) of a
FIG. 2. Nucleotide sequence alignment of the 59UTR fragment of HCV recovered from serum, PBMCs and various organs from HIV-1 positive
patients. The sequences are compared with the prototype sequence HCV-1 published by Choo et al. (1991) shown on the top line. (.) Sequence identity
with HCV-1; (-) gap introduced in sequence to preserve alignment. In patients (Pt) 1, 4, and 5, consensus viral sequences amplified from serum (S)
and PBMCs (C) differed by 2 to 14 nucleotide substitutions. In patient 6 ‘‘master’’ sequences recovered from serum and multiple organs were identical;
however sequences amplified from pancreas (P) and adrenal gland were composed of two major population, one being identical to the consensus
sequence and the other one differing by one nucleotide substitution and one nucleotide insertion. Similarly, sequences amplified from the lymph node
(L) from patient 7 also contained a dual population of consensus sequence identical to sequence recovered from serum and other organs, and
another one differing by two nucleotide substitutions.
TABLE 1
The Detection of Positive and Negative Strands of HCV RNA in
Serum and Peripheral Blood Mononuclear Cells (PBMCs) in Five
HIV-Infected Patients
Patient
Serum (Eq/ml)a
PBMCs (genomic eq/
2–3 3 106 cells)a
1 strand 2 strand 1 strand 2 strand
1. 5 3 105 Neg 103 102
2. 5 3 107 Neg 103 Neg
3. 5 3 106 Neg 103 Neg
4. 5 3 107 Neg 104 102
5. 5 3 106 Neg 103 Neg
a The presence and titers of the positive (1) strand were determined
by MMLV RT-based assay, while the presence of the negative (2)
strand was determined by a Tth-based assay. Neg, negative.
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patient with chronic hepatitis C. As long as the template
remained concentrated, the SSCP bands were consis-
tently identical; however, when template was end-point
diluted, the band pattern became erratic and inconsis-
tent from run to run, indicating the presence of diverse
viral sequences.
DISCUSSION
In the current study we compared HCV sequences
amplified from serum, PBMCs, and various tissues in a
group of patients infected with HIV-1. Out of the three
viral regions compared, 59UTR, NS5, and E2, differences
were commonly encountered in the first but not in the
other two regions. Moreover, the presence of 59 UTR
sequences differing from those circulating in serum cor-
related with active viral replication, as determined by the
presence of HCV RNA negative strand, in all but one
sample. However, it is likely that in this single case
where 59UTR differences were not reflected by the pres-
ence of viral negative strand the replication was below
the sensitivity limit of our strand-specific assay. The
59UTR differences were already evident at the level of
‘‘master’’ sequences in case of PBMCs but solid organs
always contained a significant admixture of serum se-
quence. This was most likely related to the fact that
serum contamination could be efficiently prevented only
in the former. Our results are highly unlikely to be arti-
factual as they were repeatable in at least two experi-
ments using independently extracted RNA and extensive
measures, outlined in Materials and Methods, were un-
dertaken to lower the risk of sporadic artifactual poly-
morphism.
These two independent lines of evidence, viral se-
quence differences and the presence of RNA negative
strand in the same tissues, strongly argue for the genu-
ine presence of extrahepatic HCV replication, at least in
FIG. 3. Analysis by SSCP of HCV sequences amplified from serum (S)
and various autopsy tissues from patient 6. The examined tissues included
liver (Lv), lymph node (LN), bone marrow (BM), pancreas (Pn), thyroid (Th),
adrenal gland (AG), kidney (Kd), lung (Lg), skeletal muscle (Ms), and skin
(Sk). The band pattern of NS5 and E2 region sequences is identical for all
samples; however, 59UTR band patterns from pancreas (Pn) and adrenal
gland (AG) are different from the rest of the samples. The presence of
identical and dissimilar 59UTR viral sequences was verified by direct
sequencing and/or sequencing of individual bands extracted from the
SSCP gel; these sequences are illustrated in Fig. 2.
FIG. 4. Analysis by SSCP of HCV sequences amplified from serum (S)
and various autopsy tissues from patient 7. The examined samples in-
cluded liver (Lv), lymph node (LN), bone marrow (BM), pancreas (Pn),
thyroid (Th), adrenal gland (AG), kidney (Kd), lung (Lg), skeletal muscle
(Ms), and skin (Sk). Because E2 region could not be amplified, only 59UTR
and NS5 regions were analyzed. The band pattern of NS5 region se-
quences is identical for all samples; however, 59UTR sequences recov-
ered from lymph node (LN) are clearly different from the rest of the
samples. The presence of identical and dissimilar 59UTR viral sequences
was verified by direct sequencing and/or sequencing of individual bands
extracted from the SSCP gel; these sequences are illustrated in Fig. 2.
TABLE 2
The Detection of Positive and Negative Strands of HCV RNA in Serum Samples and Various Tissues from Two Patients with AIDS
Patient
Tissue (genomic eq/ug RNA)a
Serum
(eq/ml)a Liver
Bone
marrow
Lymph
node Pancreas Thyroid
Adrenal
gland Kidney Lung Muscle Skin
1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2 1 2
6. 5 3 104 N 107 105 103 N 103 N 103 P 102 N 104 P 103 N 104 N 101 N 102 N
7. 5 3 105 N 107 106 102 N 104 102 102 N 102 N 103 N 102 N 103 N 101 N 103 N
a The presence and titers of the positive (1) strand were determined by MMLV RT-based assay, while the presence and titers of the negative (2)
strand were determined by a Tth-based assay N, negative; P, positive in 5–6 mg of total RNA.
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the setting of HIV-1 infection. The existence of extrahe-
patic replication could have implications for therapy and
for the understanding of different extrahepatic manifes-
tations of HCV infection, the pathogenesis of which are
currently obscure (Willson, 1997). For example, chronic
HCV infection was associated with B-cell lymphoprolif-
erative disorders such as mixed cryoglobulinemia and
B-cell non-Hodgkin lymphoma (Pozzato et al., 1994; Ferri
et al., 1996) as well as with the development of diabetes
mellitus (Alison et al., 1994; Pozzato et al., 1994).
Several attempts were previously made to compare
HCV quasispecies recovered from liver, serum, and oc-
casionally PBMCs. These studies, which were almost
uniformly confined to E2 region, provided conflicting re-
sults ranging from absolute concordance to total discor-
dance between these viral populations (Sakamoto et al.,
1995; Fuji et al., 1996; Cabot et al., 1997; Maggi et al.,
1997; Navas et al., 1998). However, both commonly used
techniques, SSCP and sequencing of cloned PCR prod-
ucts, have significant pitfalls: both are clearly affected by
low copy number template, especially when such a vari-
able region as E2 is used for analysis, and the latter
technique is particularly vulnerable to the introduction of
artificial polymorphism during PCR amplification or clon-
ing (Smith et al., 1997). In our study, which rigorously
adhered to specific criteria for results validation, we did
not find any differences in E2 region patterns between
different tissues, but it should be stressed that the nature
of quasispecies may be less complex in the setting of
HIV-1 infection, possibly reflecting diminished immune
pressure against the HVR1.
The biological significance of identified 59UTR differ-
ences is currently unclear. The 59UTR, which is the most
conserved part in the whole viral genome, contains an
internal ribosomal entry site allowing viral translation in
a cap-independent manner (Tsukiyama-Kohara et al.,
1992; Honda et al., 1996). Such structures were identified
first within the 59UTR of the picornaviruses (Pelletier and
Sonenberg, 1988; Jang and Wimmer, 1990) and were
shown to interact with a variety of cellular proteins;
moreover, these interactions seem to be important in
determining the host range of individual viruses (Agol,
1991). Taking this into consideration, it could be specu-
lated that some of the identified changes may represent
tissue-specific adjustment although it cannot be ex-
cluded that such adaptive alterations are in fact localized
in others parts of viral genome. Although the biological
consequences of the 59UTR variations remain to be de-
termined by studies in vitro, they could be a simple and
sensitive marker of extrahepatic HCV replication.
MATERIALS AND METHODS
Biological samples
PBMCs were collected from five HIV-1 positive drug
addicts who were found to be HCV RNA positive in
serum. All patients were HBsAg negative, and none had
received any antiviral therapy prior to the study. PBMCs
were isolated by Ficoll-Hypaque (Pharmacia, Uppsala,
Sweden) density-gradient centrifugation, washed three
times with PBS (pH 7.4) and stored frozen at 280°C until
use. RNA was extracted from 5 3 106 to 1 3 107 cells or
100 ml of serum by means of a modified guanidinium
thiocyanate-phenol/chloroform technique using commer-
cially available kits (Ultraspec 2 and Ultraspec 3; Biotecx
Laboratories, Houston, TX) and finally dissolved in 30 ml
of water. Ten microliters of this RNA solution was reverse
transcribed as further described; in the case of serum,
the amount of extracted RNA loaded into reaction corre-
sponded to 20 ml.
Tissue samples were collected from two HIV-1–in-
fected drug addicts who died from AIDS-related compli-
cations. These were obtained during routine autopsy
conducted within 48 h of death and stored at 280°C until
analysis. Samples of the following tissues were collected
from each patient: liver, bone marrow, mediastinal lymph
node, pancreas, thyroid, adrenal gland, kidney, lung,
skeletal muscle, and skin.
FIG. 5. The detection of HCV RNA negative strands in various tissue
samples from two HIV-1 infected patients who died of AIDS-related
complications. To ensure strand specificity, Tth-based RT-PCR assay
was used, as described in the text. The amount of RNA loaded into
each reaction was 1 mg for liver and 5 to 6 mg for other tissue samples;
in case of serum (S) it corresponded to 20 ml. The examined tissues
included liver (Lv), lymph node (LN), bone marrow (BM), pancreas (Pn),
thyroid (Th), adrenal gland (AG), kidney (Kd), lung (Lg), skeletal muscle
(Ms), and skin (Sk). Negative controls (lanes N) consisted of RNA
extracted from livers from uninfected subjects, and positive/sensitivity
controls (lanes P) consisted of end-point dilutions of the negative
synthetic strand (100 genomic eq).
FIG. 6. The influence of HCV template titer on the reliability of
sequence comparison in the 59UTR. Positive (L1) and negative (L2)
RNA strands were amplified from liver and positive strands were
amplified from serum (S) from the same patient with chronic hepatitis
C. When concentrated template was amplified, the SSCP bands were
identical (lanes 1 to 3); however, when template was end-point diluted
the band pattern became inconsistent indicating the presence of di-
verse viral sequences.
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RNA was extracted after tissue homogenization as
described above. For each sample, two different
amounts of extracted RNA (5 to 6 and 1 mg, as deter-
mined by spectrophotometry) were initially used for RT-
PCR. These values were not chosen arbitrarily because
in preliminary studies we determined that RNA concen-
trations higher than 6 mg markedly inhibit reaction.
Whenever a sample was positive at a concentration of 1
mg RNA, the RNA template was serially 10-fold diluted in
water for the purpose of titer determination.
Synthetic HCV RNA
To generate synthetic positive and negative HCV
strands, PCR product encompassing the 59untranslated
region (59UTR) of the virus was cloned into a plasmid
vector (pGEM-3Z, Promega, Madison, WI) and after plas-
mid linearization subsequently transcribed with T7 poly-
merase (Riboprobe Transcription System; Promega) as
described elsewhere (Laskus et al., 1997a).
Strand-specific RT-PCR with Tth
The Tth-based RT-PCR detection of the negative HCV
RNA strand was performed as described elsewhere
(Laskus et al., 1997a); in brief, the cDNA was generated
in 20 ml of reaction mixture containing 50 pM of sense
primer (59A/GAC/TCACTCCCCTGTGAGGAAC; nt 35 to 55
39), 13 RT buffer (Perkin-Elmer), 1 mM MnCl2, 200 mM
(each) dNTP, and 5 U Tth (Perkin-Elmer). After 20 min at
65°C, Mn21 were chelated with 8 ml of 103 EGTA che-
lating buffer (Perkin-Elmer), 50 pM of antisense primer
(TGA/GTGCACGGTCTACGAGACCTC 39; nt 342 to 320)
was added, the volume was adjusted to 100 ml, and the
MgCl2 concentration was adjusted to 2.2 mM. The am-
plification was performed in a Perkin-Elmer GenAmp
PCR System 9600 thermocycler as follows: initial dena-
turing for 1 min at 94°C, 50 cycles of 94°C for 15 s, 58°C
for 30 s, and 72°C for 30 s followed by a final extension
at 72°C for 7 min. PCR products were analyzed as de-
scribed above. Twenty microliters of the final product
were analyzed by agarose gel electrophoresis and
Southern hybridization with a 32P-labeled internal oligo-
probe 59 ACTGTCTTCACGCAGAAAGCGTC 39; nt 57 to
79. As described in our previous report (Laskus et al.,
1997a) and as illustrated in Fig. 7, this assay was capa-
ble of detecting about 100 genomic equivalent (eq) mol-
ecules of the correct strand while unspecifically detect-
ing $108 genomic eq of the incorrect strand. When 1 or
6 mg of total cellular RNA extracted from normal human
livers was added, the sensitivity of the reactions was
lowered by no more than 1 log while the specificity of the
assay was not affected.
RT-PCR with MMLV RT
MMLV RT-based detection of HCV RNA has been de-
scribed in detail elsewhere (Laskus et al., 1997a,b). This
assay was found to be very sensitive but totally unspe-
cific. As reported elsewhere (Laskus et al., 1997a), it was
capable of detecting 10 genomic eq of the correct tem-
plate but at the same time it also unspecifically detected
$101–103 genomic eq of the positive strand.
All titers were determined by analyzing 10-fold serial
dilutions of the RNA template because at this dilution,
the results were reliably reproducible from run to run.
The titers were calculated by assuming that the end-
point dilution contains 10 genomic eq when tested by the
MMLV RT-based assay and 102 genomic eq when tested
with the Tth-based assay.
To prevent contamination, pre-PCR and post-PCR
steps were carried out in separate rooms. To detect
carryover contamination, negative controls were in-
cluded in all reaction series: one negative sample was
processed for every three to four tested specimens, and
FIG. 7. The sensitivity and specificity of Tth-based RT-PCR. Positive and negative RNA strands were made by in vitro ‘‘run off’’ transcription with
T7 RNA polymerase from a vector (pGEM-3Z) containing the 59 untranslated sequence of HCV and serially diluted in water. The number of target
template copies was calculated from OD readings. A positive-sense primer was present during cDNA synthesis after which the enzyme was
inactivated by chelating with Mn21 and then negative-sense primer was added. Samples were amplified as described in the text. Twenty ml (20%)
of the reaction were separated on 2.5% agarose, transferred to nylon membranes and hybridized to a 32P labeled probe. When 1 or 6 mg of cellular
RNA extracted from normal human livers was added, the sensitivity of the reactions was lowered by up to 1 log, but the specificity of the assay was
not affected.
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nontarget controls were included into each run. Under
these conditions, none of the negative samples or con-
trols was positive.
To increase the specificity and sensitivity of our as-
says, wax beads (Ampliwax; Perkin-Elmer) were used for
‘‘hot start’’ of all PCR after the RT step. All RT-PCR runs
included positive controls consisting of end-point dilu-
tions of respective RNA strands and negative controls
included normal livers and normal sera.
Analysis of HCV quasispecies
For the purpose of sequence comparison, ‘‘nested’’
protocols were routinely used to maximize the yield of
PCR product. Amplification of 59UTR was conducted with
RT-PCR assay as described (Laskus et al., 1997a); inter-
nal primers were 59ACTGTCTTCACGCAGAAAGCGTC
39(nt 57 to 79) and 59CAAGCACCCTATCAGGCAGTACC 39
(nt 307 to 285).
For amplification of the NS5 region the following prim-
ers were used: 59 GGCGGAATTCCTGGTCATAGCCTC-
CGTGAA 39(nt 8645 to 8616) and 59TGGGGATCCCGTAT-
GATACCCGCTGC/TTTC/TGA 39(nt 8245 to 8275) for the
first round and primers 59 CGCTTTCACAGATAACGACTA-
AGT 39 (nt 8580 to 8557) and 59 CTCCACAGTCACT-
GAGAGCGACAT 39 (nt 8276 to 8299) for the second
round.
The E2 region, including the hypervariable region
(HVR1), was amplified using primers 59 ASGGGGCT-
GGGA/GGTGAAA/GCAATAT/CAC 39(nt 1882 to 1857) and
59 CATGGGATATGATGATGAAC/TTGGT 39 (nt 1297 to
1320) for the first round and 59 AGGCTATCATTGCAAC-
CAG (nt 1639 to 1620) and 59 GCTGCTCCGGATCCCACA
39 (nt 1349 to 1366) for the ‘‘nested’’ round. However, if
amplification with these primers was unsuccessful, other
primers were tried (Cabot et al., 1997).
For comparing HCV quasispecies, single-strand con-
formation polymorphism (SSCP) analysis was used as it
is less prone to sporadic artifactual polymorphism than
cloning of PCR products and subsequent analysis of
individual clones (Smith et al., 1997). PCR products were
purified with a DNA binding resin system (Wizard PCR,
Promega, WI). The purified product (0.1 mg) in 9 ml of
alkali denaturing buffer (50 Mm NaOH, 1 Mm EDTA) was
mixed with 1 ml of SSCP loading buffer (95% formamide,
0.5% bromphenol blue, 0.5% xylene cyanol) and was
subjected to nondenaturing PAGE in 13 Tris-borate-
EDTA buffer with 400 V applied for 4 to 6 h at a constant
temperature of 25°C. The bands were visualized with
silver staining (Silver Stain, Promega). By serial dilutions
of different samples we found that the limit of detection
for various band patterns was 0.5 to 3 ng; thus the
technique was able to detect a minor variant admixture
representing about 3% of the whole population.
Subsequently, all PCR products revealing differences
on SSCP analysis were sequenced directly in both di-
rections by the Sanger dideoxy chain termination method
with a modified T7 DNA polymerase (Sequenase version
2.0 kit; United States Biochemical). When necessary,
individual bands were extracted from the gel, reampli-
fied, and then sequenced directly.
For extraction of DNA from silver-stained PAGE, the
following protocol was established. The appropriate sin-
gle band was cut out of the gel, crushed with a pipet tip
in a 1.5 ml Eppendorf tube after which 300 ml of water
was added and the tube was shaken at 37°C for 6 h.
Next, the DNA solution was separated from the gel
particles by filtering through a 0.45-mm syringe filter
(Whatman; Clifton, NJ), purified on a Wizard column (Pro-
mega) and concentrated in 50 ml of water. This solution
(10 ml) was added into the PCR reaction and reamplified
using the original primers.
Measures aimed at validating sequence comparison
results. The following measures have been implemented
throughout the study to lower the risk of sporadic arti-
factual polymorphism:
1. Whenever SSCP analysis revealed differences be-
tween sequences, the analysis was repeated in an
independent experiment using new RNA template.
Both these reactions had to be identical when run
next to each other on the same SSCP gel before the
experiment was considered to be valid.
2. To rule out sampling error due to low copy number
of the template, samples showing SSCP band pat-
tern different from serum were serially diluted 10-
fold to check for titer. The samples were considered
suitable for analysis only if they were positive at a
dilution 1:100 or higher.
3. To lower the risk of artifacts related to high copy
number template (Wang et al., 1997), products of the
first round of amplification were diluted 1:100 be-
fore they were used as template for the second
round of PCR.
4. Samples persistently showing different band pat-
tern on SSCP were first sequenced directly in both
directions. When no differences in the master se-
quence were seen, individual bands were se-
quenced after they were extracted from the gel and
reamplified. To rule out incorporation errors by Taq
polymerase, all direct sequencing was routinely
repeated from a new amplification reaction. Clon-
ing, which carries a high risk of introducing artificial
polymorphism, was avoided.
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